| SW620, GI50=5.0±0.4μM (control: Doxorubicin, GI50=0.34μM); A549, GI50=11±3μM (control: Doxorubicin, GI50=0.21μM); PC3, GI50=3.4±0.3μM (control: Doxorubicin, GI50=0.0.39μM); LOX-IMVI, GI50=2.6±0.3μM (control: Doxorubicin, GI50=0.12μM); HCT15, GI50=4.1±0.3μM (control: Doxorubicin, GI50=0.84μM); SW620 cells, 0.5% tween 80, ip60mg/ (kg.d)22d tumor volum reduce 14.6% |